Skip to main content
SpringerLink
Log in

Primary Tumors of the Pleura

  • Chapter
  • First Online:
The Thorax

Part of the book series: Cancer Dissemination Pathways ((CDP))

  • 547 Accesses

Abstract

The pleura may be affected by primary or metastatic tumor spread of either intrathoracic or extrathoracic neoplasms. Primary pleural tumors are rare, representing approximately 10% of all pleural neoplasms. Malignant lesions are more common than benign ones. Malignant pleural mesothelioma (MPM) and solitary fibrous tumor of the pleura (SFTP) represent the two most common primary tumors. Primary neoplasms also include lymphoma, epithelioid hemangioendothelioma, synovial sarcoma, and other rarer entities.

Metastatic disease accounts for about 90% of pleural tumors. Cross-sectional imaging – computed tomography (CT) and magnetic resonance imaging (MRI) – play a pivotal role in both diagnosis and staging of pleural neoplasms, particularly for the depiction of patterns of cancer dissemination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mossman BT, Shukla A, Heintz NH, Verschraegen CF, Thomas A, Hassan R. New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. Am J Pathol. 2013;182:1065–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Galateau-Salle F, Churg A, Roggli V, Travis WD. World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. J Thorac Oncol. 2016;11:142–54.

    Article  PubMed  Google Scholar 

  3. Nickell LT Jr, Lichtenberger JP 3rd, Khorashadi L, Abbott GF, Carter BW. Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma. Radiographics. 2014;34:1692–706.

    Article  PubMed  Google Scholar 

  4. Opitz I. Management of malignant pleural mesothelioma-The European experience. J Thorac Dis. 2014;6 Suppl 2:S238–52.

    PubMed  Google Scholar 

  5. Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, Maskell NA, Psallidas I. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016;25:472–86.

    Article  PubMed  Google Scholar 

  6. Carter BW, Betancourt SL, Shroff GS, Lichtenberger JP 3rd. MR imaging of pleural neoplasms. Top Magn Reson Imaging. 2018;27:73–82.

    Article  PubMed  Google Scholar 

  7. Liu B, van Gerwen M, Bonassi S, Taioli E. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12:1031–45.

    Article  PubMed  Google Scholar 

  8. Rossini M, Rizzo P, Bononi I, Clementz A, Ferrari R, Martini F, Tognon MG. New perspectives on diagnosis and therapy of malignant pleural mesothelioma. Front Oncol. 2018;8:91.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Wu L, Dell’Anno I, Lapidot M, Sekido Y, Chan M-L, Kohno M, Serre-Beinier V, Felley-Bosco E, de Perrot M. Progress of malignant mesothelioma research in basic science: a review of the 14th international conference of the international mesothelioma interest group (iMig2018). Lung Cancer. 2019;127:138–45.

    Article  PubMed  Google Scholar 

  10. Kato K, Gemba K, Fujimoto N, Aoe K, Takeshima Y, Inai K, Kishimoto T. Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. Eur J Radiol. 2016;85:1594–600.

    Article  PubMed  Google Scholar 

  11. Gemba K, Fujimoto N, Kato K, Aoe K, Takeshima Y, Inai K, Kishimoto T. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 2012;103:483–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Røe OD, Stella GM. Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic. Eur Respir Rev. 2015;24:115–31.

    Article  PubMed  Google Scholar 

  13. Chang ET, Lau EC, Mowat FS, Teta MJ. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma. Cancer Causes Control. 2017;28:971–9.

    Article  PubMed  Google Scholar 

  14. Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, Bonafede M, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Mazzoleni G, Merler E, Girardi P, Negro C, D’Agostin F, Romanelli A, Chellini E, Silvestri S, Pascucci C, Calisti R, Stracci F, Romeo E, Ascoli V, Trafficante L, Carrozza F, Angelillo IF, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M, Iavicoli S, ReNaM Working Group. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75:254–62.

    Article  PubMed  Google Scholar 

  15. De Rienzo A, Archer MA, Yeap BY, Dao N, Sciaranghella D, Sideris AC, Zheng Y, Holman AG, Wang YE, Dal Cin PS, Fletcher JA, Rubio R, Croft L, Quackenbush J, Sugarbaker PE, Munir KJ, Battilana JR, Gustafson CE, Chirieac LR, Ching SM, Wong J, Tay LC, Rudd S, Hercus R, Sugarbaker DJ, Richards WG, Bueno R. Gender-specific molecular and clinical features underlie malignant pleural mesothelioma. Cancer Res. 2016;76:319–28.

    Article  PubMed  CAS  Google Scholar 

  16. Alì G, Bruno R, Fontanini G. The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review. J Thorac Dis. 2018;10:S276–84.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Nind NR, Attanoos RL, Gibbs AR. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma. Histopathology. 2003;42:150–5.

    Article  CAS  PubMed  Google Scholar 

  18. Escalon JG, Harrington KA, Plodkowski AJ, Zheng J, Capanu M, Zauderer MG, Rusch VW, Ginsberg MS. Malignant pleural mesothelioma: are there imaging characteristics associated with different histologic subtypes on computed tomography? J Comput Assist Tomogr. 2018;42:601–6.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Karpathiou G, Stefanou D, Froudarakis ME. Pleural neoplastic pathology. Respir Med. 2015;109:931–43.

    Article  PubMed  Google Scholar 

  20. Parker C, Neville E. Lung cancer ∗ 8: management of malignant mesothelioma. Thorax. 2003;58:809–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sahin N, Akatli AN, Celik MR, Ulutas H, Samdanci ET, Colak C. The role of CD90 in the differential diagnosis of pleural malignant mesothelioma, pulmonary carcinoma and comparison with calretının. Pathol Oncol Res. 2017;23:487–91.

    Article  CAS  PubMed  Google Scholar 

  22. Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M, International Mesothelioma Interest Group. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2013;137:647–67.

    Article  PubMed  Google Scholar 

  23. Mann S, Khawar S, Moran C, Kalhor N. Revisiting localized malignant mesothelioma. Ann Diagn Pathol. 2019;39:74–7.

    Article  PubMed  Google Scholar 

  24. Yao W, Yang H, Huang G, Yan Y, Wang H, Sun D. Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases. Int J Clin Exp Med. 2015;8:18367–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Hino T, Kamitani T, Sagiyama K, Yamasaki Y, Okamoto I, Tagawa T, Ijichi K, Yamamoto H, Yabuuchi H, Honda H. Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor. Eur J Radiol Open. 2019;6:72–7.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kim K-C, Vo H-P. Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor. J Thorac Dis. 2016;8:E379–84.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Berzenji L, Van Schil PE, Carp L. The eighth TNM classification for malignant pleural mesothelioma. Transl Lung Cancer Res. 2018;7:543–9.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax. 2009;64:139–43.

    Article  CAS  PubMed  Google Scholar 

  29. Falaschi F, Romei C, Fiorini S, Lucchi M. Imaging of malignant pleural mesothelioma: it is possible a screening or early diagnosis program? – a systematic review about the use of screening programs in a population of asbestos exposed workers. J Thorac Dis. 2018;10:S262–8.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Wang ZJ, Reddy GP, Gotway MB, Higgins CB, Jablons DM, Ramaswamy M, Hawkins RA, Webb WR. Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET. Radiographics. 2004;24:105–19.

    Article  PubMed  Google Scholar 

  31. Jeong YJ, Kim S, Kwak SW, Lee NK, Lee JW, Kim KI, Choi KU, Jeon TY. Neoplastic and nonneoplastic conditions of serosal membrane origin: CT findings. Radiographics. 2008;28:801–17; discussion 817–8; quiz 912.

    Article  PubMed  Google Scholar 

  32. Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E, Bortolotti L, Zanello A, Ceresoli GL. Clinical staging of malignant pleural mesothelioma: current perspectives. Lung Cancer. 2017;8:127–39.

    PubMed  PubMed Central  Google Scholar 

  33. Hallifax RJ, Talwar A, Wrightson JM, Edey A, Gleeson FV. State-of-the-art: radiological investigation of pleural disease. Respir Med. 2017;124:88–99.

    Article  CAS  PubMed  Google Scholar 

  34. Kim YK, Kim JS, Lee KW, Yi CA, Goo JM, Jung S-H. Multidetector CT findings and differential diagnoses of malignant pleural mesothelioma and metastatic pleural diseases in Korea. Korean J Radiol. 2016;17:545–53.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Metintas M, Ucgun I, Elbek O, Erginel S, Metintas S, Kolsuz M, Harmanci E, Alatas F, Hillerdal G, Ozkan R, Kaya T. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases. Eur J Radiol. 2002;41:1–9.

    Article  PubMed  Google Scholar 

  36. Pessôa FMC, de Melo ASA, Souza AS Jr, de Souza LS, Hochhegger B, Zanetti G, Marchiori E. Applications of magnetic resonance imaging of the thorax in pleural diseases: a state-of-the-art review. Lung. 2016;194:501–9.

    Article  PubMed  Google Scholar 

  37. Gill RR, Gerbaudo VH, Jacobson FL, Trotman-Dickenson B, Matsuoka S, Hunsaker A, Sugarbaker DJ, Hatabu H. MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am. 2008;16:319–39, x.

    Article  PubMed  Google Scholar 

  38. Pena E, Ojiaku M, Inacio JR, Gupta A, Macdonald DB, Shabana W, Seely JM, Rybicki FJ, Dennie C, Thornhill RE. Can CT and MR shape and textural features differentiate benign versus malignant pleural lesions? Acad Radiol. 2017;24:1277–87.

    Article  PubMed  Google Scholar 

  39. Coolen J, De Keyzer F, Nafteux P, De Wever W, Dooms C, Vansteenkiste J, Roebben I, Verbeken E, De Leyn P, Van Raemdonck D, Nackaerts K, Dymarkowski S, Verschakelen J. Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging-initial experience. Radiology. 2012;263(3):884–92.

    Article  PubMed  Google Scholar 

  40. Gill RR, Umeoka S, Mamata H, Tilleman TR, Stanwell P, Woodhams R, Padera RF, Sugarbaker DJ, Hatabu H. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol. 2010;195(2):W125–30.

    Article  PubMed  Google Scholar 

  41. Armato SG 3rd, Blyth KG, Keating JJ, Katz S, Tsim S, Coolen J, Gudmundsson E, Opitz I, Nowak AK. Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2016;101:48–58.

    Article  PubMed  Google Scholar 

  42. Patel AM, Berger I, Wileyto EP, Khalid U, Torigian DA, Nachiappan AC, Barbosa EM Jr, Gefter WB, Galperin-Aizenberg M, Gupta NK, Simone CB 2nd, Haas AR, Alley EW, Singhal S, Cengel KA, Katz SI. The value of delayed phase enhanced imaging in malignant pleural mesothelioma. J Thorac Dis. 2017;9:2344–9.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Armato SG 3rd, Francis RJ, Katz SI, Ak G, Opitz I, Gudmundsson E, Blyth KG, Gupta A. Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer. 2019;130:108–14.

    Article  PubMed  Google Scholar 

  44. Vivoda Tomšič M, Bisdas S, Kovač V, Serša I, Šurlan Popovič K. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria. Cancer Imaging. 2019;19:10.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Gudmundsson E, Labby Z, Straus CM, Sensakovic WF, Li F, Rose B, Cunliffe A, Kindler HL, Armato SG 3rd. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study. Eur Radiol. 2019;29:682–8.

    Article  PubMed  Google Scholar 

  46. Armato SG, Nowak AK. Revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (version 1.1). J Thorac Oncol. 2018;13:1012–21.

    Article  PubMed  Google Scholar 

  47. Murphy DJ, Mak SM, Mallia A, Jeljeli S, Stirling JJ, Goh V, Bille A, Cook GJR. Loco-regional staging of malignant pleural mesothelioma by integrated 18F-FDG PET/MRI. Eur J Radiol. 2019;115:46–52.

    Article  CAS  PubMed  Google Scholar 

  48. Kitajima K, Doi H, Kuribayashi K. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma. Jpn J Radiol. 2016;34:537–47.

    Article  CAS  PubMed  Google Scholar 

  49. Tan C, Barrington S, Rankin S, Landau D, Pilling J, Spicer J, Cane P, Lang-Lazdunski L. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma. J Thorac Oncol. Elsevier;. 2010;5:385–8.

    Article  PubMed  Google Scholar 

  50. Rusch VW, Giroux D, Kennedy C, Ruffini E, Cangir AK, Rice D, Pass H, Asamura H, Waller D, Edwards J, Weder W, Hoffmann H, van Meerbeeck JP, IASLC Staging Committee. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7:1631–9.

    Article  PubMed  Google Scholar 

  51. Gomez DR, Rimner A, Simone CB, John Cho BC, de Perrot M, Adjei AA, Bueno R, Gill RR, Harpole DH Jr, Hesdorffer M, Hirsch FR, Jackson AA, Pass HI, Rice DC, Rusch VW, Tsao AS, Yorke E, Rosenzweig K. The use of radiation therapy for the treatment of malignant pleural mesothelioma: expert opinion from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol. 2019;14:1172–83.

    Article  PubMed  Google Scholar 

  52. Miyazaki T, Yamasaki N, Tsuchiya T, Matsumoto K, Kamohara R, Hatachi G, Nagayasu T. Is pleurectomy/decortication superior to extrapleural pneumonectomy for patients with malignant pleural mesothelioma? A single-institutional experience. Ann Thorac Cardiovasc Surg. 2018;24:81–8.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Verma V, Ahern CA, Berlind CG, Lindsay WD, Sharma S, Shabason J, Culligan MJ, Grover S, Friedberg JS, Simone CB 2nd. National cancer database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma. J Thorac Oncol. 2017;12:1704–14.

    Article  PubMed  Google Scholar 

  54. Odisio EG, Marom EM, Shroff GS, Wu CC, Benveniste APA, Truong MT, Benveniste MF. Malignant pleural mesothelioma: diagnosis, staging, pitfalls and follow-up. Semin Ultrasound CT MR. 2017;38:559–70.

    Article  PubMed  Google Scholar 

  55. Murthy V, Katzman D, Sterman DH. Intrapleural immunotherapy: an update on emerging treatment strategies for pleural malignancy. Clin Respir J. 2019;13:272–9.

    Article  PubMed  Google Scholar 

  56. Cramer G, Simone CB 2nd, Busch TM, Cengel KA. Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma. J Thorac Dis. 2018;10:S2565–73.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Taioli E, Wolf AS, Camacho-Rivera M, Flores RM. Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg. 2014;98:1020–4.

    Article  PubMed  Google Scholar 

  58. van Gerwen M, Alpert N, Wolf A, Ohri N, Lewis E, Rosenzweig KE, Flores R, Taioli E. Prognostic factors of survival in patients with malignant pleural mesothelioma; an analysis of the National Cancer Data Base. Carcinogenesis. 2019;40(4):529–36.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  59. Finn RS, Brims FJH, Gandhi A, Olsen N, Musk AW, Maskell NA, Lee YCG. Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients. Chest. 2012;142:1267–73.

    Article  PubMed  Google Scholar 

  60. Jayaranagaiah A, Kariyanna PT, Chidella NKS, Singh N, Green J, Salifu MO, McFarlane S. Malignant pleural mesothelioma presenting with cardiac tamponade- a rare case report and review of the literature. Clin Case Rep Rev 2018;4(5).

    Google Scholar 

  61. Marom EM, Erasmus JJ, Pass HI, Patz EF Jr. The role of imaging in malignant pleural mesothelioma. Semin Oncol. 2002;29:26–35.

    Article  PubMed  Google Scholar 

  62. Robinson BWS, Lake RA. Advances in malignant mesothelioma. N Engl J Med. Massachusetts Medical Society;. 2005;353:1591–603.

    Article  CAS  PubMed  Google Scholar 

  63. Bergamin S, Tio M, Stevens MJ. Prophylactic procedure tract radiotherapy for malignant pleural mesothelioma: a systematic review and meta-analysis. Clin Transl Radiat Oncol. 2018;13:38–43.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Clive AO, Taylor H, Dobson L, Wilson P, de Winton E, Panakis N, Pepperell J, Howell T, Stewart SA, Penz E, Jordan N, Morley AJ, Zahan-Evans N, Smith S, Batchelor TJP, Marchbank A, Bishop L, Ionescu AA, Bayne M, Cooper S, Kerry A, Jenkins P, Toy E, Vigneswaran V, Gildersleve J, Ahmed M, McDonald F, Button M, Lewanski C, Comins C, Dakshinamoorthy M, Lee YCG, Rahman NM, Maskell NA. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial. Lancet Oncol. 2016;17:1094–104.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Ideguchi R, Ashizawa K, Akashi S, Shindo M, Minami K, Fukuda T, Uetani M. Malignant pleural mesothelioma with marked lymphatic involvement: a report of two autopsy cases. Case Rep Oncol Med. 2017;2017:6195898.

    PubMed  PubMed Central  Google Scholar 

  66. Berger I, Cengel KA, Simone CB 2nd, Alley EW, Roshkovan L, Haas AR, Patel AM, Khalid U, Culligan MJ, McNulty S, Singhal S, Friedberg JS, Katz SI. Lymphangitic carcinomatosis: a common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma. Lung Cancer. 2019;132:94–8.

    Article  PubMed  Google Scholar 

  67. Okten F, Köksal D, Onal M, Ozcan A, Simşek C, Ertürk H. Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos. Clin Imaging. 2006;30:177–80.

    Article  PubMed  Google Scholar 

  68. Wu H, Tino G, Gannon FH, Kaiser LR, Pietra GG. Lepidic intrapulmonary growth of malignant mesothelioma presenting as recurrent hydropneumothorax. Hum Pathol. 1996;27:989–92.

    Article  CAS  PubMed  Google Scholar 

  69. Rice D, Chansky K, Nowak A, Pass H, Kindler H, Shemanski L, Opitz I, Call S, Hasegawa S, Kernstine K, Atinkaya C, Rea F, Nafteux P, Rusch VW, Mesothelioma Domain of the IASLC Staging and Prognostic Factors Committee, advisory boards and participating institutions. The IASLC mesothelioma staging project: proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol. Elsevier;. 2016;11:2100–11.

    Article  PubMed  Google Scholar 

  70. Seely JM, Nguyen ET, Churg AM, Müller NL. Malignant pleural mesothelioma: computed tomography and correlation with histology. Eur J Radiol. 2009;70:485–91.

    Article  PubMed  Google Scholar 

  71. Schouwink JH, Kool LS, Rutgers EJ, Zoetmulder FAN, van Zandwijk N, v d Vijver MJ, Baas P. The value of chest computer tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thorac Surg. 2003;75:1715–8; discussion 1718–9.

    Article  PubMed  Google Scholar 

  72. Ohno Y, Yui M, Aoyagi K, Kishida Y, Seki S, Koyama H, Yoshikawa T. Whole-body MRI: comparison of its capability for TNM staging of malignant pleural mesothelioma with that of coregistered PET/MRI, integrated FDG PET/CT, and conventional imaging. AJR Am J Roentgenol. 2019;212:311–9.

    Article  PubMed  Google Scholar 

  73. Yamagishi T, Fujimoto N, Miyamoto Y, Asano M, Fuchimoto Y, Wada S, Kitamura K, Ozaki S, Nishi H, Kishimoto T. Brain metastases in malignant pleural mesothelioma. Clin Exp Metastasis. 2016;33:231–7.

    Article  CAS  PubMed  Google Scholar 

  74. Lester T, Xu H. Malignant pleural mesothelioma with osseous metastases and pathologic fracture of femoral neck. Appl Immunohistochem Mol Morphol. 2008;16:507–9.

    Article  PubMed  Google Scholar 

  75. Tanwar M, Simone CB 2nd, Newman S, Cengel K, Yu GH, Melhem ER, Mohan S. Perineural spread of malignant mesothelioma with spinal intramedullary involvement. Clin Neurol Neurosurg. 2014;120:116–9.

    Article  PubMed  Google Scholar 

  76. Yao MJ, Ding L, Atay SM, Toubat O, Ebner P, David EA, McFadden PM, Kim AW. A modern reaffirmation of surgery as the optimal treatment for solitary fibrous tumors of the pleura. Ann Thorac Surg. 2019;107:941–6.

    Article  PubMed  Google Scholar 

  77. Attanoos RL, Pugh MR. The diagnosis of pleural tumors other than mesothelioma. Arch Pathol Lab Med. 2018;142:902–13.

    Article  PubMed  Google Scholar 

  78. Bishop AJ, Zagars GK, Demicco EG, Wang W-L, Feig BW, Guadagnolo BA. Soft tissue solitary fibrous tumor: combined surgery and radiation therapy results in excellent local control. Am J Clin Oncol. 2018;41:81–5.

    Article  PubMed  Google Scholar 

  79. Song Z, Yang F, Zhang Y, Fan P, Liu G, Li C, Ding W, Zhang Y, Xu X, Ye Y. Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura. Onco Targets Ther. 2018;11:5227–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Liu CC, Wang HW, Li FY, Hsu PK, Huang MH, Hsu WH, Wang LS. Solitary fibrous tumors of the pleura: clinicopathological characteristics, immunohistochemical profiles, and surgical outcomes with long-term follow-up. Thorac Cardiovasc Surg. 2008;56:291–7.

    Article  PubMed  Google Scholar 

  81. Hélage S, Revel MP, Chabi ML, Audureau É, Ferretti G, Laurent F, Alifano M, Mansuet-Lupo A, Buy JN, Vadrot D. Solitary fibrous tumor of the pleura: can computed tomography features help predict malignancy? A series of 56 patients with histopathological correlates. Diagn Interv Imaging. 2016;97:347–53.

    Article  PubMed  Google Scholar 

  82. de Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg. 2002;74(1):285–93.

    Article  PubMed  Google Scholar 

  83. Erb CT, Johnson KM, Kim AW. Rare pleural tumors. Clin Chest Med. 2013;34:113–36.

    Article  PubMed  Google Scholar 

  84. Ershadi R, Rahim M, Abbasi M, Erfanian R. Giant solitary fibrous tumor of the pleura. J Surg Case Rep. 2018;20188(11):rjy270.

    Google Scholar 

  85. Abu Arab W. Solitary fibrous tumours of the pleura. Eur J Cardiothorac Surg. Narnia;. 2012;41:587–97.

    Article  PubMed  Google Scholar 

  86. Rosado-de-Christenson ML, Abbott GF, McAdams HP, Franks TJ, Galvin JR. From the archives of the AFIP: localized fibrous tumor of the pleura. Radiographics. 2003;23:759–83.

    Article  PubMed  Google Scholar 

  87. Inaoka T, Takahashi K, Miyokawa N, Ohsaki Y, Aburano T. Solitary fibrous tumor of the pleura: apparent diffusion coefficient (ADC) value and ADC map to predict malignant transformation. J Magn Reson Imaging. 2007;26:155–8.

    Article  PubMed  Google Scholar 

  88. Cardillo G, Carbone L, Carleo F, Masala N, Graziano P, Bray A, Martelli M. Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg. 2009;88:1632–7.

    Article  PubMed  Google Scholar 

  89. Kohler M, Clarenbach CF, Kestenholz P, Kurrer M, Steinert HC, Russi EW, Weder W. Diagnosis, treatment and long-term outcome of solitary fibrous tumours of the pleura. Eur J Cardiothorac Surg. 2007;32:403–8.

    Article  PubMed  Google Scholar 

  90. Robinson LA. Solitary fibrous tumor of the pleura. Cancer Control. 2006;13:264–9.

    Article  PubMed  Google Scholar 

  91. Cortes J, Rodriguez J, Garcia-Velloso MJ, Rodriguez-Espiteri N, Boan JF, Castellano JM, Torre W. [(18)F]-FDG PET and localized fibrous mesothelioma. Lung. 2003;181:49–54.

    Article  CAS  PubMed  Google Scholar 

  92. Shinya T, Masaoka Y, Sando M, Tanabe S, Okamoto S, Ihara H, Tanaka T, Otani S, Hiraki T, Kanazawa S. Imaging an intrapulmonary solitary fibrous tumor with CT and F-18 FDG PET/CT. Radiol Case Rep. 2019;14:755–8.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Ginat DT, Bokhari A, Bhatt S, Dogra V. Imaging features of solitary fibrous tumors. AJR Am J Roentgenol. 2011;196:487–95.

    Article  PubMed  Google Scholar 

  94. Tazeler Z, Tan G, Aslan A, Tan S. The utility of 18F-FDG PET/CT in solitary fibrous tumors of the pleura. Rev Esp Med Nucl Imagen Mol. 2016;35:165–70.

    CAS  PubMed  Google Scholar 

  95. Yeom YK, Kim MY, Lee HJ, Kim SS. Solitary fibrous tumors of the pleura of the thorax: CT and FDG PET characteristics in a tertiary referral center. Medicine. 2015;94:e1548.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Chick JFB, Chauhan NR, Madan R. Solitary fibrous tumors of the thorax: nomenclature, epidemiology, radiologic and pathologic findings, differential diagnoses, and management. AJR Am J Roentgenol. 2013;200:W238–48.

    Article  PubMed  Google Scholar 

  97. Friis RB, Safwat A, Baad-Hansen T, Aggerholm-Pedersen N. Solitary fibrous tumour: a single institution retrospective study and further validation of a prognostic risk assessment system. Clin Oncol. 2018;30:798–804.

    Article  CAS  Google Scholar 

  98. Arab WA. Solitary fibrous tumours of the pleura. Eur J Cardiothorac Surg. 2012;41:587–97.

    Article  PubMed  Google Scholar 

  99. Steiropoulos P, Kouliatsis G, Karpathiou G, Popidou M, Froudarakis ME. Rare cases of primary pleural Hodgkin and non-Hodgkin lymphomas. Respiration. 2009;77:459–63.

    Article  PubMed  Google Scholar 

  100. Bligh MP, Borgaonkar JN, Burrell SC, MacDonald DA, Manos D. Spectrum of CT findings in thoracic extranodal non-Hodgkin lymphoma. Radiographics. 2017;37:439–61.

    Article  PubMed  Google Scholar 

  101. Borie R, Wislez M, Antoine M, Cadranel J. Lymphoproliferative disorders of the lung. Respiration. 2017;94:157–75.

    Article  PubMed  Google Scholar 

  102. Arora N, Gupta A, Sadeghi N. Primary effusion lymphoma: current concepts and management. Curr Opin Pulm Med. 2017;23:365–70.

    Article  PubMed  Google Scholar 

  103. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018;93:953–62.

    Article  CAS  PubMed  Google Scholar 

  104. Nakatsuka S-I, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K. Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol. 2002;20:4255–60.

    Article  PubMed  Google Scholar 

  105. Kligerman SJ, Franks TJ, Galvin JR. Primary extranodal lymphoma of the thorax. Radiol Clin N Am. 2016;54:673–87.

    Article  PubMed  Google Scholar 

  106. Bugalho A, Ferreira D, Dias SS, Schuhmann M, Branco JC, Marques Gomes MJ, Eberhardt R. The diagnostic value of transthoracic ultrasonographic features in predicting malignancy in undiagnosed pleural effusions: a prospective observational study. Respiration. 2014;87:270–8.

    Article  PubMed  Google Scholar 

  107. Sharma A, Fidias P, Hayman LA, Loomis SL, Taber KH, Aquino SL. Patterns of lymphadenopathy in thoracic malignancies. Radiographics. 2004;24:419–34.

    Article  PubMed  Google Scholar 

  108. Fan Y, Wang F, Li S, Ye C, Ying Y, Mao H. Pleural epithelioid hemangioendothelioma: a case report and literature review. J Natl Med Assoc. 2016;108:124–9.

    Article  PubMed  Google Scholar 

  109. Granville L, Laga AC, Allen TC, Dishop M, Roggli VL, Churg A, Zander DS, Cagle PT. Review and update of uncommon primary pleural tumors: a practical approach to diagnosis. Arch Pathol Lab Med. 2005;129:1428–43.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Scienze Radiologiche – Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy

    Roberta Eufrasia Ledda, Claudia Commisso & Nicola Sverzellati

  2. SCDU Radiodiagnostica e Medicina Nucleare, Azienza Ospedaliero-Universitaria S Luigi Gonzaga, Orbassano, Italy

    Luciano Cardinale

Authors
  1. Roberta Eufrasia Ledda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudia Commisso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luciano Cardinale
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nicola Sverzellati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicola Sverzellati .

Editor information

Editors and Affiliations

  1. Scienze Radiologiche – Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy

    Nicola Sverzellati

  2. Scienze Radiologiche – Department of Medicine and Surgery (DiMeC), University of Parma, Parma, Italy

    Mario Silva

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ledda, R.E., Commisso, C., Cardinale, L., Sverzellati, N. (2020). Primary Tumors of the Pleura. In: Sverzellati, N., Silva, M. (eds) The Thorax. Cancer Dissemination Pathways. Springer, Cham. https://doi.org/10.1007/978-3-030-27233-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27233-3_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27232-6

  • Online ISBN: 978-3-030-27233-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation